Mets Morning Roundup – March 10th 2025

Here is your Mets Morning Roundup for March 10, 2025 on of some things happening in Mets land.

Mets have the 12th best farm system in the Majors

​In MLB.com’s 2025 preseason farm system rankings, the New York Mets are positioned at No. 12, reflecting a robust collection of talent that balances immediate contributors with promising future assets.  Three Top 100 prospects headline the system:​

  • Brandon Sproat, a right-handed pitcher ranked No. 46,​
  • Jett Williams, a versatile shortstop/outfielder at No. 57,​
  • Carson Benge is an outfielder who recently entered the Top 100 at No. 100. ​

This trio exemplifies the Mets’ commitment to developing a pipeline to support the major league roster in the short and long term.​

MLB Farm System Preseason Ranking – MLB.com

Notably, six of the Mets’ top 11 prospects have estimated times of arrival (ETAs) set for 2025, indicating a potential influx of young talent ready to make an impact this season.  This depth gives the organization flexibility and optimism, as these players are poised to complement the Mets’ veteran core. The balanced approach in their farm system underscores the franchise’s strategy of blending experienced leadership with youthful exuberance, aiming to sustain competitiveness in the challenging National League East division.

Will Brett Baty make the cut?

​Brett Baty has been a standout performer for the New York Mets during the 2025 Spring Training, showcasing significant improvements at the plate. Over 24 at-bats, Baty has maintained an impressive .375 batting average, hitting two home runs and accumulating five RBIs, resulting in a robust 1.152 OPS.  This offensive surge reflects his dedication to refining his approach during the offseason, focusing on swinging at strikes and maintaining composure with two strikes. Baty’s consistent performance has not only highlighted his offensive capabilities but also his adaptability and readiness for a more prominent role with the Mets. ​

Beyond his batting prowess, Baty’s versatility in the infield has been a valuable asset for the Mets. Comfortable in multiple positions, he has provided the team with flexibility in their lineup configurations. His strong start this spring has positioned him as a leading candidate for a roster spot, especially with the competition intensifying due to injuries within the team. Manager Carlos Mendoza has praised Baty’s improved rhythm and strike zone control, indicating confidence in his ability to transition his spring success into the regular season.  As the Mets approach Opening Day, Baty’s performance continues to be a focal point, we’ll see if he can grab the last roster spot on the 40 man roster for Opening Day.

Brett Baty
Brett Baty

Clay Holmes great spring start

​Clay Holmes has been a standout performer for the New York Mets during the 2025 Spring Training, particularly as he transitions from a reliever to a starter. In his recent outing against the Washington Nationals, Holmes delivered an impressive performance, pitching 3 2/3 scoreless innings, allowing only one hit, issuing three walks, and striking out eight batters—a personal best surpassing his previous career-high of six strikeouts. Over his three spring starts, he has accumulated 9 2/3 innings without surrendering a run, yielding just two hits and four walks while striking out 13. ​

A significant factor in Holmes’ success has been the development of his changeup, a pitch he had set aside since becoming a full-time reliever in 2019. In his latest start, with his signature sinker not performing optimally, Holmes effectively utilized his changeup, inducing ground balls and swings and misses. This adaptability demonstrates his growing confidence in his expanded pitch repertoire, a crucial aspect as he prepares to face batting orders multiple times in a game.Mets manager Carlos Mendoza praised Holmes’ ability to navigate innings even when his primary pitch wasn’t at its best, highlighting the importance of a diverse arsenal in his transition to the starting rotation

Former Met, Mo Vaughn, admits to using HGH to extend his career

Former Major League Baseball star Mo Vaughn, affectionately known as “The Hit Dog,” recently admitted to using human growth hormone (HGH) during his career. In an interview with The Athletic, Vaughn revealed that he resorted to HGH injections in his knee to manage a degenerative condition, stating, “I was trying to do everything I could. I knew I had a bad, degenerative knee.” This admission sheds light on the physical toll that professional athletes endure in their pursuit of excellence.

This confession aligns with Vaughn’s inclusion in the 2007 Mitchell Report, which documented his purchase of HGH in 2001, before MLB’s ban on the substance in 2005. At the time, Vaughn did not publicly address these allegations. Reflecting on his career, Vaughn expressed that his use of HGH was an attempt to prolong his time in the majors amidst persistent knee issues. ​

Vaughn’s career spanned from 1991 to 2003, during which he played for the Boston Red Sox, Anaheim Angels, and New York Mets. He was a three-time All-Star and earned the American League MVP award in 1995. Despite his on-field success, Vaughn’s later years were marred by injuries, leading to his retirement in 2003

Mo Vaughn, fearsome slugger named in Mitchell Report, admits to using HGH: Exclusive – The Athletic


More content below:

More From Author

You May Also Like

6 comments

Leave a Reply